National Fertilizer Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 28, 2025, 8:55 am

Competitors of National Fertilizer Ltd

All Competitor Stocks of National Fertilizer Ltd

Quarterly Result

Last Updated: August 20, 2025, 6:25 am

Below is a detailed analysis of the quarterly data for National Fertilizer Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 3,534.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,457.00 Cr. (Mar 2025) to 3,534.00 Cr., marking a decrease of 923.00 Cr..
• For Expenses, as of Jun 2025, the value is 3,453.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4,222.00 Cr. (Mar 2025) to 3,453.00 Cr., marking a decrease of 769.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 81.00 Cr.. The value appears to be declining and may need further review. It has decreased from 234.00 Cr. (Mar 2025) to 81.00 Cr., marking a decrease of 153.00 Cr..
• For OPM %, as of Jun 2025, the value is 2.00%. The value appears to be declining and may need further review. It has decreased from 5.00% (Mar 2025) to 2.00%, marking a decrease of 3.00%.
• For Other Income, as of Jun 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 62.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 53.00 Cr..
• For Interest, as of Jun 2025, the value is 46.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 35.00 Cr. (Mar 2025) to 46.00 Cr., marking an increase of 11.00 Cr..
• For Depreciation, as of Jun 2025, the value is 96.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 95.00 Cr. (Mar 2025) to 96.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is -52.00 Cr.. The value appears to be declining and may need further review. It has decreased from 167.00 Cr. (Mar 2025) to -52.00 Cr., marking a decrease of 219.00 Cr..
• For Tax %, as of Jun 2025, the value is -24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 19.00% (Mar 2025) to -24.00%, marking a decrease of 43.00%.
• For Net Profit, as of Jun 2025, the value is -39.00 Cr.. The value appears to be declining and may need further review. It has decreased from 135.00 Cr. (Mar 2025) to -39.00 Cr., marking a decrease of 174.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.80. The value appears to be declining and may need further review. It has decreased from 2.75 (Mar 2025) to -0.80, marking a decrease of 3.55.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:48 am

Growth

Last Updated: September 5, 2025, 11:35 am

Balance Sheet

Last Updated: September 10, 2025, 2:07 pm

Below is a detailed analysis of the balance sheet data for National Fertilizer Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 491.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 491.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,225.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,055.00 Cr. (Mar 2024) to 2,225.00 Cr., marking an increase of 170.00 Cr..
• For Borrowings, as of Mar 2025, the value is 2,001.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 4,091.00 Cr. (Mar 2024) to 2,001.00 Cr., marking a decrease of 2,090.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 4,599.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4,563.00 Cr. (Mar 2024) to 4,599.00 Cr., marking an increase of 36.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 9,316.00 Cr.. The value appears to be improving (decreasing). It has decreased from 11,199.00 Cr. (Mar 2024) to 9,316.00 Cr., marking a decrease of 1,883.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 3,694.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,831.00 Cr. (Mar 2024) to 3,694.00 Cr., marking a decrease of 137.00 Cr..
• For CWIP, as of Mar 2025, the value is 172.00 Cr.. The value appears to be declining and may need further review. It has decreased from 242.00 Cr. (Mar 2024) to 172.00 Cr., marking a decrease of 70.00 Cr..
• For Investments, as of Mar 2025, the value is 443.00 Cr.. The value appears strong and on an upward trend. It has increased from 336.00 Cr. (Mar 2024) to 443.00 Cr., marking an increase of 107.00 Cr..
• For Other Assets, as of Mar 2025, the value is 5,007.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6,791.00 Cr. (Mar 2024) to 5,007.00 Cr., marking a decrease of 1,784.00 Cr..
• For Total Assets, as of Mar 2025, the value is 9,316.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11,199.00 Cr. (Mar 2024) to 9,316.00 Cr., marking a decrease of 1,883.00 Cr..

Notably, the Reserves (2,225.00 Cr.) exceed the Borrowings (2,001.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for National Fertilizer Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 3.75. This value is below the healthy minimum of 5. It has increased from 3.06 (Mar 24) to 3.75, marking an increase of 0.69.
• For Diluted EPS (Rs.), as of Mar 25, the value is 3.75. This value is below the healthy minimum of 5. It has increased from 3.06 (Mar 24) to 3.75, marking an increase of 0.69.
• For Cash EPS (Rs.), as of Mar 25, the value is 9.16. This value is within the healthy range. It has increased from 8.69 (Mar 24) to 9.16, marking an increase of 0.47.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 55.36. It has increased from 52.07 (Mar 24) to 55.36, marking an increase of 3.29.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 55.36. It has increased from 52.07 (Mar 24) to 55.36, marking an increase of 3.29.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 403.49. It has decreased from 480.25 (Mar 24) to 403.49, marking a decrease of 76.76.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 14.32. This value is within the healthy range. It has decreased from 14.63 (Mar 24) to 14.32, marking a decrease of 0.31.
• For PBIT / Share (Rs.), as of Mar 25, the value is 6.72. This value is within the healthy range. It has decreased from 7.25 (Mar 24) to 6.72, marking a decrease of 0.53.
• For PBT / Share (Rs.), as of Mar 25, the value is 2.12. This value is within the healthy range. It has increased from 1.80 (Mar 24) to 2.12, marking an increase of 0.32.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 1.55. This value is below the healthy minimum of 2. It has increased from 1.32 (Mar 24) to 1.55, marking an increase of 0.23.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.75. This value is within the healthy range. It has increased from 3.06 (Mar 24) to 3.75, marking an increase of 0.69.
• For PBDIT Margin (%), as of Mar 25, the value is 3.55. This value is below the healthy minimum of 10. It has increased from 3.04 (Mar 24) to 3.55, marking an increase of 0.51.
• For PBIT Margin (%), as of Mar 25, the value is 1.66. This value is below the healthy minimum of 10. It has increased from 1.51 (Mar 24) to 1.66, marking an increase of 0.15.
• For PBT Margin (%), as of Mar 25, the value is 0.52. This value is below the healthy minimum of 10. It has increased from 0.37 (Mar 24) to 0.52, marking an increase of 0.15.
• For Net Profit Margin (%), as of Mar 25, the value is 0.38. This value is below the healthy minimum of 5. It has increased from 0.27 (Mar 24) to 0.38, marking an increase of 0.11.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 8. It has increased from 0.63 (Mar 24) to 0.92, marking an increase of 0.29.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.77. This value is below the healthy minimum of 15. It has increased from 5.87 (Mar 24) to 6.77, marking an increase of 0.90.
• For Return on Capital Employeed (%), as of Mar 25, the value is 7.49. This value is below the healthy minimum of 10. It has decreased from 8.03 (Mar 24) to 7.49, marking a decrease of 0.54.
• For Return On Assets (%), as of Mar 25, the value is 1.97. This value is below the healthy minimum of 5. It has increased from 1.33 (Mar 24) to 1.97, marking an increase of 0.64.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.73. This value is within the healthy range. It has decreased from 1.60 (Mar 24) to 0.73, marking a decrease of 0.87.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.93. It has decreased from 1.98 (Mar 24) to 1.93, marking a decrease of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 1.01. This value is below the healthy minimum of 1.5. It has increased from 0.98 (Mar 24) to 1.01, marking an increase of 0.03.
• For Quick Ratio (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has increased from 0.72 (Mar 24) to 0.82, marking an increase of 0.10.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 14.88. This value exceeds the healthy maximum of 8. It has increased from 3.16 (Mar 24) to 14.88, marking an increase of 11.72.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 7.20. This value is below the healthy minimum of 20. It has decreased from 91.21 (Mar 24) to 7.20, marking a decrease of 84.01.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 2.37. This value is below the healthy minimum of 20. It has decreased from 26.74 (Mar 24) to 2.37, marking a decrease of 24.37.
• For Earning Retention Ratio (%), as of Mar 25, the value is 92.80. This value exceeds the healthy maximum of 70. It has increased from 8.79 (Mar 24) to 92.80, marking an increase of 84.01.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 97.63. This value exceeds the healthy maximum of 70. It has increased from 73.26 (Mar 24) to 97.63, marking an increase of 24.37.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.11. This value is within the healthy range. It has increased from 2.68 (Mar 24) to 3.11, marking an increase of 0.43.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.34. This value is below the healthy minimum of 3. It has increased from 1.24 (Mar 24) to 1.34, marking an increase of 0.10.
• For Enterprise Value (Cr.), as of Mar 25, the value is 5,905.78. It has decreased from 8,348.85 (Mar 24) to 5,905.78, marking a decrease of 2,443.07.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 1. It has decreased from 0.35 (Mar 24) to 0.29, marking a decrease of 0.06.
• For EV / EBITDA (X), as of Mar 25, the value is 8.40. This value is within the healthy range. It has decreased from 11.64 (Mar 24) to 8.40, marking a decrease of 3.24.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 1. It has increased from 0.18 (Mar 24) to 0.19, marking an increase of 0.01.
• For Retention Ratios (%), as of Mar 25, the value is 92.79. This value exceeds the healthy maximum of 70. It has increased from 8.78 (Mar 24) to 92.79, marking an increase of 84.01.
• For Price / BV (X), as of Mar 25, the value is 1.45. This value is within the healthy range. It has decreased from 1.68 (Mar 24) to 1.45, marking a decrease of 0.23.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.19. This value is below the healthy minimum of 1. It has increased from 0.18 (Mar 24) to 0.19, marking an increase of 0.01.
• For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness